Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 1—January 2006

Vaccines for Pandemic Influenza

Catherine J. Luke* and Kanta Subbarao*Comments to Author 
Author affiliations: *National Institutes of Health, Bethesda, Maryland, USA

Main Article

Table 4

Preclinical testing to be performed on live attenuated pandemic influenza vaccine candidates

In vitro testing In vivo testing
Confirmation of virus genome sequence
Trypsin-dependent replication in cell culture
Confirmation of phenotype associated with the vaccine donor virus, e.g., temperature sensitivity, cold adaptation Intravenous pathogenicity test in chickens
Attenuation (restricted replication) in rodent or ferret model
Immunogenicity in rodent or ferret model
Protective efficacy in rodent model

Main Article

Page created: February 16, 2012
Page updated: February 16, 2012
Page reviewed: February 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.